NCT02420405View on ClinicalTrials.gov

Mutation Detection of EBUS-TBNA Specimens Using NGS

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2016

Conditions
Lung Cancer
Interventions
PROCEDURE

Routine gene testing

For those diagnosed with nonsquamous NSCLC, routine gene testing including EGFR, ROS1 and ALK will be performed.

PROCEDURE

Next-generation sequencing

For those diagnosed with nonsquamous NSCLC and have done routine gene testing, NGS will be perform on those that have adequate rest tissues.

Trial Locations (1)

200030

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Jiayuan Sun

OTHER

NCT02420405 - Mutation Detection of EBUS-TBNA Specimens Using NGS | Biotech Hunter | Biotech Hunter